Bio‑Key Q1 2026: Revenue Growth, Improving EPS and a Profit‑Focused Outlook
Bio‑key International’s Q1 2026 results show modest revenue growth and an improving loss margin, with strong new deals driving optimism for Q2 profitability.
3 minutes to read




